Active substanceSulfanilamideSulfanilamide
Similar drugsTo uncover
  • Streptocide
    powder externally 
    LEKAR, LLC     Russia
  • Streptocide
    powder externally 
  • Streptocide
    powder externally 
  • Streptocide
    powder externally 
  • Streptocide
    ointment externally 
    BIOSINTEZ, PAO     Russia
  • Streptocide
    powder externally 
    LYUMI, LLC     Russia
  • Streptocide
    powder externally 
  • Streptocide
    ointment externally 
  • Streptocide
    powder externally 
    YUZHFARM, LLC     Russia
  • Streptocide
    ointment externally 
    GREEN DUBRAVA, CJSC     Russia
  • Streptocide
    ointment externally 
  • Streptocide
    powder externally 
  • Streptocide soluble
    liniment externally 
    NIZHFARM, JSC     Russia
  • Streptocide-LexT
    powder externally 
    PATENT-FARM, CJSC     Russia
  • Streptocide Ointment 10%
    ointment externally 
  • Dosage form: & nbspointment for external use
    Composition:

    Active substance:

    Sulfanilamide (streptocid) - 10 g

    Excipient:

    Vaseline - 90 g.

    Description:Ointment is white or light yellow in color.
    Pharmacotherapeutic group:Antimicrobial agent - sulfonamide
    ATX: & nbsp

    D.06.B.A   Sulfonamides

    Pharmacodynamics:

    Antimicrobial bacteriostatic agent, sulfanilamide. The mechanism of action is due to competitive antagonism with para-aminobenzoic acid, inhibition of dihydropteroate synthetase, a violation of the synthesis of tetrahydrofolic acid necessary for the synthesis of purines and pyrimidines. It is active against gram-positive and gram-negative cocci, Escherichia coli, Shigella spp.,Vibrio cholerae, Clostridium perfringens, Bacillus anthracis, Corynebacterium diphtheria, Yersinia pestis, Chlamydia spp., Actinomyces istraelii, Toxoplasma gondii.

    Indications:

    As part of complex therapy: purulent wounds, infected burns (I-II etc.) and other purulent-inflammatory processes of the skin.

    Contraindications:

    Hypersensitivity to sulfonamides, diseases of the hematopoietic system, oppression of bone marrow hematopoiesis, anemia, chronic heart failure, thyrotoxicosis, renal-hepatic insufficiency, azotemia, porphyria, congenital deficiency of glucose-6-phosphate dehydrogenase, pregnancy, breast-feeding period.

    Pregnancy and lactation:

    Contraindicated.

    Dosing and Administration:

    Outwardly.

    The ointment is applied directly to the affected surface of the skin or to a gauze napkin; dressing produced after 1-2 days.The course of treatment is 10-14 days.

    If there is no improvement within 10-14 days, you should consult a doctor. Use the drug only according to the method of administration and the doses specified in the instructions. If necessary, please consult with your doctor before using the medication.

    Side effects:

    Allergic reactions; with prolonged use of large doses - a systemic action: headache, dizziness, nausea, vomiting, dyspepsia, cyanosis, crystalluria.

    If any of the side effects listed in the manual are aggravated, or if you notice any other side effects not listed in the instructions, report it the doctor.

    Overdose:

    Symptoms: nausea, vomiting, intestinal colic, dizziness, headache, drowsiness, depression, fainting, confusion, visual impairment, fever, hematuria, crystalluria; with prolonged overdose - thrombocytopenia, leukopenia, megaloblastic anemia, jaundice. Treatment: abundant drink; with accidental ingestion - gastric lavage; symptomatic therapy.

    Interaction:

    Myelotoxic drugs increase the manifestation of hematotoxicity of the drug.

    If you are taking other medications (including over-the-counter drugs) before using Streptocid, consult a doctor.

    Special instructions:

    Premature termination of treatment with the drug may promote the development of resistant strains of microorganisms to sulfanilamides.

    During therapy, an abundant alkaline drink is recommended.

    If necessary, concomitantly prescribe antimicrobials inwards. When developing allergic reactions, it is necessary to cancel the drug and prescribe the appropriate treatment.

    Effect on the ability to drive transp. cf. and fur:

    Given the side effects of the drug, care should be taken when driving vehicles, mechanisms.

    Form release / dosage:

    Ointment for external use 10%.

    Packaging:

    For 25, 30 and 50 g in dark glass jars with a screw neck, or 25, 30 and 50 g in glass jars with a triangular whisk with lids pullable.

    By 25, 30 and 50 g in cans of polymer complete with lids or cans of polyethylene terephthalate with the means of corking.

    By 25, 30 and 50 g in aluminum tubes, coated with BF-2 varnish, with caps made of high-density polyethylene or low-density polyethylene, or in the lips, laminate caps.

    Each jar or tube together with the instruction for use is placed in a pack of cardboard box for consumer packaging or cardboard chromium-ersatz. The text of the instructions for use on the secondary packaging (bundle) for the can is allowed. It is allowed to pack cans or tubes without a bundle from 9 to 300 pieces together with an equal number of instructions for use in a carton box (for hospitals).

    Storage conditions:

    In the dark place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    5 years. Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-004191
    Date of registration:15.03.2017
    Expiration Date:15.03.2022
    The owner of the registration certificate:IVANOVSKAYA Pharmaceutical Factory, OAO IVANOVSKAYA Pharmaceutical Factory, OAO Russia
    Manufacturer: & nbsp
    Information update date: & nbsp04.04.2017
    Illustrated instructions
      Instructions
      Up